Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy-Reference-Cited by-同舟云学术

Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy

Published:2020-05 Issue:5 Volume:43 Page:527-533
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing Clin Electrophysiol

Author:

Kohli Utkarsh¹^ORCID,Aziz Zaid²,Beaser Andrew D.²,Nayak Hemal M.²

Affiliation:

1. Division of Pediatric Cardiology, Department of PediatricsComer Children's Hospital and the Pritzker School of Medicine of the University of Chicago Chicago Illinois

2. Center for Arrhythmia Care, Heart and Vascular CenterPritzker School of Medicine of the University of Chicago Chicago Illinois

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pace.13913

Reference22 articles.

1. A large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia

2. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia

3. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

4. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review

5. The Clinical Use of Ivabradine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the diagnosis and management of premature ventricular contractions in pediatric patients;Frontiers in Pediatrics;2024-03-20

2. Catecholaminergic Polymorphic Ventricular Tachycardia;Cardiac Electrophysiology Clinics;2023-09

3. Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs;Journal of Clinical Medicine;2022-06-06

4. The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels;Frontiers in Pharmacology;2022-05-02

5. The HCN channel as a pharmacological target: Why, where, and how to block it;Progress in Biophysics and Molecular Biology;2021-11